The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.
Carter P, Alifrangis C, Chandrasinghe P, Cereser B, Del Bel Belluz L, Leo CA, Moderau N, Tabassum N, Warusavitarne J, Krell J, Stebbing J.
Carter P, et al.
Oncotarget. 2018 Jan 16;9(13):11371-11376. doi: 10.18632/oncotarget.24257. eCollection 2018 Feb 16.
Oncotarget. 2018.
PMID: 29541419
Free PMC article.